marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q2
added 08-21-2023
Timber Pharmaceuticals Balance Sheet 2011-2024 | TMBR
Annual Balance Sheet Timber Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-16.1 M | -549 K | -3.07 M | -7.58 M | -6.5 M | -4.04 M | -1.09 M | -1.91 M | -162 | - | - | |
Long Term Debt |
- | 331 K | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
331 K | 333 K | 218 K | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 59 K | 39 K | 403 K | - | - | - | - | - | - |
Total Current Liabilities |
5.04 M | 4.19 M | 1.38 M | 2.3 M | 2.98 M | 3.73 M | 2.8 M | 1.56 M | 1.37 M | 771 K | 75.5 K | 58.7 K |
Total Liabilities |
5.04 M | 4.63 M | 2.47 M | 2.36 M | 3.02 M | 4.13 M | 2.8 M | 8.38 M | 8.1 M | 123 K | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-48.3 M | -28.9 M | -88.2 M | -78.5 M | -61.3 M | -44.6 M | -26.2 M | -10.6 M | -9.49 M | - | - | - |
Total Assets |
10.3 M | 17.9 M | 2.13 M | 3.65 M | 8.09 M | 7.1 M | 4.85 M | 2.17 M | 2.99 M | 162 | - | - |
Cash and Cash Equivalents |
9.08 M | 16.8 M | 10.3 M | 3.07 M | 7.58 M | 6.5 M | 4.04 M | 1.3 M | 2.11 M | 162 | 4.64 K | 15.6 K |
Book Value |
5.23 M | 13.3 M | -339 K | 1.3 M | 5.07 M | 2.97 M | 2.05 M | -6.21 M | -5.11 M | -123 K | - | - |
Total Shareholders Equity |
5.23 M | 13.3 M | 7.61 M | -1.38 M | 5.07 M | 2.97 M | 2.05 M | -6.21 M | -5.11 M | -1.37 M | -46 K | 1.46 K |
All numbers in USD currency
Quarterly Balance Sheet Timber Pharmaceuticals
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
323 K | 298 K | - | 83.5 K | 164 K | 242 K | 331 K | 420 K | 506 K | 588 K | 579 K | 579 K | 579 K | 579 K | 1 M | 826 K | 891 K | 956 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.65 M | 1.13 B | - | - | - | 200 M | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | 59 K | - | - | - | 39 K | 67 K | 114 K | 142 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
5.95 M | 4.97 M | 5.04 M | 5.16 M | 8.56 M | 4.22 M | 4.63 M | 2.59 M | 2.9 M | 2.07 M | 2.11 M | 2.11 M | 2.11 M | 2.11 M | 1.47 M | 1.47 M | 1.47 M | 3.51 M | 3.02 M | 3.12 M | 3.17 M | 3.21 M | 4.13 M | 3.78 M | 4.08 M | 4.85 M | 2.8 M | 6.66 M | - | - | - | - | - | - | 1.37 M | 1.81 M | 1.19 M | 2.74 M | 1.74 M | 1.74 M | 1.74 M | 1.74 M | 198 K | 75.5 K | 75.5 K | 75.5 K | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-56.4 M | -52.3 M | -48.3 M | -44.6 M | -41.5 M | -32 M | -28.9 M | -26.1 M | -23.1 M | -20.1 M | -18.2 M | -18.2 M | -18.2 M | -18.2 M | -3.08 M | -3.08 M | -3.08 M | -82.2 M | -61.3 M | -74.5 M | -70.1 M | -65.7 M | -44.6 M | -57.5 M | -53.8 M | -50 M | -26.2 M | -39.6 M | -35.7 M | -30.7 M | - | -21.7 M | -17.8 M | -14.3 M | -9.49 M | - | - | - | -1.68 M | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
3.33 M | 6.28 M | 10.3 M | 12.8 M | 9.91 M | 14.8 M | 17.9 M | 4.55 M | 7.69 M | 9.77 M | 11.6 M | 11.6 M | 11.6 M | 11.6 M | 89.9 K | 89.9 K | 89.9 K | 4.93 M | 8.09 M | 3.72 M | 7.43 M | 11.4 M | 7.1 M | 2.45 M | 5.23 M | 7.25 M | 4.85 M | 1.63 M | 1.38 M | 4.81 M | - | 3.24 M | 8.64 M | 1.82 M | 2.99 M | 1.93 M | 1.64 M | 453 K | 371 K | 371 K | 371 K | 371 K | 152 K | 4.85 K | 4.85 K | 2.07 K | 11.8 K | 16 K | 16 K | 16 K |
Cash and Cash Equivalents |
2.52 M | 5.18 M | 9.08 M | 11.2 M | 8.27 M | 13.9 M | 16.8 M | 3.36 M | 6.13 M | 8.5 M | 10.3 M | 10.3 M | 10.3 M | 10.3 M | 57.1 K | 57.1 K | 57.1 K | 3.28 M | 7.58 M | 3.02 M | 6.58 M | 10.9 M | 6.5 M | 1.58 M | 4.46 M | 6.71 M | 4.04 M | 468 K | 436 K | 4.04 M | - | 2.18 M | 7.39 M | 479 K | 2.11 M | 1.52 M | 459 K | 57 K | 3 K | 3 K | 3 K | 3 K | 138 K | 4.64 K | 4.64 K | 1.92 K | 11.4 K | 15.6 K | 15.6 K | 15.6 K |
Book Value |
-2.62 M | 1.31 M | 5.23 M | 7.63 M | 1.35 M | 10.6 M | 13.3 M | 1.97 M | 4.79 M | 7.7 M | 9.52 M | 9.52 M | 9.52 M | 9.52 M | -1.38 M | -1.38 M | -1.38 M | 1.42 M | 5.07 M | 591 K | 4.26 M | 8.23 M | 2.97 M | -1.33 M | 1.15 M | 2.4 M | 2.05 M | -5.04 M | 1.38 M | 4.81 M | - | 3.24 M | 8.64 M | 1.82 M | 1.62 M | 122 K | 459 K | -2.29 M | -1.37 M | -1.37 M | -1.37 M | -1.37 M | -46 K | -70.6 K | -70.6 K | -73.4 K | 11.8 K | 16 K | 16 K | 16 K |
Total Shareholders Equity |
-2.62 M | 1.31 M | 5.23 M | 7.63 M | 1.35 M | 10.6 M | 13.3 M | -51 K | 2.8 M | 5.76 M | 7.61 M | 7.61 M | 7.61 M | 7.61 M | -1.38 M | -1.38 M | -1.38 M | 16.3 K | 5.07 M | 591 K | 4.26 M | 8.23 M | 2.97 M | -1.33 M | 1.15 M | 2.4 M | 2.05 M | -5.04 M | -3.14 M | 1.47 M | - | 754 K | 4.34 M | -7.91 M | -5.11 M | -3.52 M | -1.65 M | -2.29 M | -1.37 M | -1.37 M | -1.37 M | -1.37 M | -46 K | -42.6 K | -70.6 K | -73.4 K | -7 K | 1.46 K | -42.6 K | -44 K |
All numbers in USD currency